Swissmedic On Project Orbis: Faster Access To Drugs, Valuable Scientific Discussions

In the first of a two-part interview with the Pink Sheet, an expert from the Swiss drug regulator explains why international collaborations are “the future” and outlines the agency’s “extremely positive” experience since joining the Project Orbis initiative three years ago.